The report also includes the diagnosed incident cases of acute PACG. The glaucoma epidemiology report is written and developed by Masters- and PhD-level epidemiologists... To know more, click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/epicast-report-glaucoma-epidemiology-forecast/142684-91.html

1. Global Glaucoma-Epidemiology Market Forecast
to 2026: Ken Research

2. Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye'soptic nerve,
resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness
worldwide, especially in elderly people. Glaucoma is generally categorized as open-angle glaucoma
(OAG), angle-closure glaucoma (ACG), or secondary glaucoma (SG), though other less common types
exist. OAG and ACG can be classified as primary (primary open-angle glaucoma [POAG] or primary
angle-closure glaucoma [PACG], respectively) or SG, depending on the cause.
To forecast the total prevalent cases of POAG, PACG, NTG, PPG, and SG in the 7MM, Global Data
epidemiologists selected nationally representative, population-based studies that provided these
epidemiological data in the 7MM. Global Data epidemiologists obtained data for the diagnosed prevalent
cases of PPG from primary market research and authentic secondary sources. In addition, the forecast is
supported by robust, country-specific data that were obtained from various authentic sources, such as
research articles published in peer-reviewed journals.

3. In the 7MM, the total prevalent cases of POAG will increase from 7,224,135 cases in 2016 to 8,549,547
cases in 2026, at an Annual Growth Rate (AGR) of 1.83%. In the 7MM, the total prevalent cases of
PACG will increase from 2,644,012 cases in 2016 to 3,124,740 cases in 2026, at an AGR of 1.82%.
Global Data forecasts that all markets will see an increase in the total prevalent cases and diagnosed
prevalent cases of POAG and PACG during the forecast period.
The Glaucoma EpiCast Report provides an overview of the risk factors and global trends of glaucoma in
the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological
forecast for the total prevalent cases and diagnosed prevalent cases of primary open-angle glaucoma
(POAG) or primary angle-closure glaucoma (PACG), segmented by sex and age (40-49 years, 50-59
years, 60-69 years, 70-79 years, and ages 80 years and older) in these markets. In addition, this report
provides a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of
glaucoma clinical types normal-tension glaucoma (NTG), pre perimetric glaucoma (PPG), and secondary
glaucoma (SG). The report also includes the diagnosed incident cases of acute PACG.

4. The glaucoma epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of
disease trends in the 7MM.
Key Topics Covered in the Report:
Global Glaucoma-Epidemiology Market Forecast
Global Glaucoma-Epidemiology Market Size
Global Glaucoma-Epidemiology Market Trends
Global Glaucoma-Epidemiology Market Outlook
Global Glaucoma-Epidemiology Market Share
Global Glaucoma-Epidemiology Market Revenue
Global Glaucoma-Epidemiology Market Volume
Global Glaucoma-Epidemiology Market Value
Global Glaucoma-Epidemiology Market
Global Glaucoma-Epidemiology Market Analysis

5. To know more, click on the link below:
https://www.kenresearch.com/healthcare/pharmaceuticals/epicast-report-glaucoma-epidemiology-
forecast/142684-91.html
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
+91-124-4230204